Stockreport

CytomX Therapeutics Inc (CTMX) Q4 2025 Earnings Call Highlights: Promising Phase 1 Data and ... [Yahoo! Finance]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF This article first appeared on GuruFocus Overall Response Rate: 32% at 10 mg/kg and 20% at 8.6 mg/kg. Progression-Free Survival: Improved to 6.8 to 7.1 months. En [Read more]